CAS: 1269815-17-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CDK-IN-2 REF: 3D-FN101837CAS: 1269815-17-9 | Min. 95% | A consultar | Mar 21 Ene 25 |
 | CDK-IN-2 REF: TM-TQ0078CAS: 1269815-17-9 | 99.52% | 40,00 €~1.096,00 € | Lun 27 Ene 25 |
 | Piperidine-3-carboxylic acid [5-chloro-4-(5-fluoro-2-methoxy-phenyl)-pyridin-2-yl]-amide REF: IN-DA009CAFCAS: 1269815-17-9 | 99% | - - - | Producto descatalogado |
CDK-IN-2
CAS:1269815-17-9
CDK-IN-2 is a novel small molecule that inhibits the activity of CDKs, which are enzymes …
Fórmula:
C18H19ClFN3O2
Pureza:
Min. 95%
Peso molecular:
363.81 g/mol
Ref: 3D-FN101837
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
CDK-IN-2
CAS:1269815-17-9
CDK-IN-2 (CDK inhibitor II) is a potent and specific CDK9 inhibitor (IC50: <8 nM).
Fórmula:
C18H19ClFN3O2
Pureza:
99.52%
Forma y color:
Solid
Peso molecular:
363.81
Ref: TM-TQ0078
| 1mg | 40,00 € | ||
| 2mg | 53,00 € | ||
| 5mg | 90,00 € | ||
| 10mg | 143,00 € | ||
| 25mg | 266,00 € | ||
| 50mg | 389,00 € | ||
| 100mg | 550,00 € | ||
| 500mg | 1.096,00 € | ||
| 1mL*10mM (DMSO) | 96,00 € |
Entrega estimada en Estados Unidos, el Lunes 27 de Enero de 2025
![Piperidine-3-carboxylic acid [5-chloro-4-(5-fluoro-2-methoxy-phenyl)-pyridin-2-yl]-amide](https://static.cymitquimica.com/products/IN/thumb/DA009CAF.jpg)
Piperidine-3-carboxylic acid [5-chloro-4-(5-fluoro-2-methoxy-phenyl)-pyridin-2-yl]-amide
CAS:1269815-17-9
Fórmula:
C18H19ClFN3O2
Pureza:
99%
Forma y color:
Solid
Peso molecular:
363.8138
Ref: IN-DA009CAF
| 1mg | Descatalogado | Solicitar información | |
| 2mg | Descatalogado | Solicitar información | |
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información | |
| 500mg | Descatalogado | Solicitar información |
